+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

The effect of suramin tumor necrosis factor and the combination of suramin plus tumor necrosis factor on human prostate carcinoma



The effect of suramin tumor necrosis factor and the combination of suramin plus tumor necrosis factor on human prostate carcinoma



Journal of Urology 143(4 SUPPL): 243A




(PDF emailed within 1 workday: $29.90)

Accession: 033784650

Download citation: RISBibTeXText



Related references

The effect of suramin, tumor necrosis factor and interferon gamma on human prostate carcinoma. Journal of Urology 145(2): 389-392, 1991

Overcoming tumor necrosis factor-alpha resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-alpha. Role of tumor necrosis factor-alpha mRNA down-regulation in tumor cell sensitization. Cancer 73(3): 730-737, 1994

Synergistic activity of suramin with tumor necrosis factor alpha and doxorubicin on human prostate cancer cell lines. Journal of the National Cancer Institute 82(14): 1206-1209, 1990

Antiproliferative effects of suramin tumor necrosis factor and interferon alpha on human prostatic carcinoma cell lines. Journal of Urology 143(4 SUPPL): 241A, 1990

Suramin induces deoligomerization of human tumor necrosis factor alpha. Journal of Biological Chemistry 268(17): 12526-9, 1993

Sensitivity of resistant human tumor cell lines to tumor necrosis factor and adriamycin used in combination: correlation between down-regulation of tumor necrosis factor-messenger RNA induction and overcoming resistance. Cancer Research 52(23): 6630-6637, 1992

Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1. American Journal of Pathology 171(5): 1713-1723, 2007

Inhibitory effect of suramin on receptor binding and cytotoxic activity of tumor necrosis factor alpha. International Journal of Immunopharmacology 14(4): 637-642, 1992

Mechanism of suramin-induced deoligomerization of tumor necrosis factor alpha. Biochemistry. 34(19): 6344-6350, 1995

Dysregulation of membrane-bound tumor necrosis factor-alpha and tumor necrosis factor receptors on mononuclear cells in human immunodeficiency virus type 1 infection: low percentage of p75-tumor necrosis factor receptor positive cells in patients with advanced disease and high viral load. Blood 90(7): 2670-2679, 1997

Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration. American Journal of Pathology 143(6): 1724-1730, 1993

Evaluation of recombinant human tumor necrosis factor by cell electrophoresis i. in vivo effect of recombinant human tumor necrosis factor on tumor cells thymocytes and lymph node cells in tumor bearing mice. Electrophoresis 8(4): 205-209, 1987

Enhancement of lymphokine-activated T killer cell tumor necrosis factor receptor mRNA transcription, tumor necrosis factor receptor membrane expression, and tumor necrosis factor/lymphotoxin release by IL-1 beta, IL-4, and IL-6 in vitro. Journal of Immunology 146(5): 1522-1526, 1991